News Archive
You may not know the human metapneumovirus by name, but chances are that you have met somewhere before.
The House panel approved legislation that would modify the health law's medical loss ratio provision to protect the earnings of insurance brokers and agents.
Idera Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.
Exalenz Bioscience, a leader in developing and marketing of non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study evaluating the potential of its BreathID test to diagnose nonalcoholic steatohepatitis (NASH).
HemoBioTech announced today the issuance of a new patent US 7,759,306 B2, Methods of Treating Acute Blood Loss. HemoBioTech has an exclusive worldwide license from Texas Tech University to commercialize the technology. The new patent continues to May 16, 2026. The major advance in HemoTech is the presence of Adenosine which has anti-inflammatory activity.
› Verified 3 days ago